Vivesto AB - Asset Resilience Ratio

Latest as of March 2026: 17.16%

Vivesto AB (VIVE) has an Asset Resilience Ratio of 17.16% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr30.51 Million

≈ $3.28 Million USD Cash + Short-term Investments

Total Assets

Skr177.85 Million

≈ $19.14 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Vivesto AB's Asset Resilience Ratio has changed over time. Check Vivesto AB strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Vivesto AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see VIVE market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr30.51 Million	17.16%
Total Liquid Assets	Skr30.51 Million	17.16%

Asset Resilience Insights

Good Liquidity Position: Vivesto AB maintains a healthy 17.16% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Vivesto AB Industry Peers by Asset Resilience Ratio

Compare Vivesto AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Vivesto AB (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Vivesto AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.05%	Skr72.00K ≈ $7.75K	Skr149.04 Million ≈ $16.04 Million	-18.18pp
2024-12-31	18.23%	Skr31.51 Million ≈ $3.39 Million	Skr172.88 Million ≈ $18.60 Million	-14.74pp
2023-12-31	32.97%	Skr72.75 Million ≈ $7.83 Million	Skr220.67 Million ≈ $23.75 Million	-4.42pp
2022-12-31	37.39%	Skr133.05 Million ≈ $14.32 Million	Skr355.88 Million ≈ $38.30 Million	+22.35pp
2021-12-31	15.04%	Skr89.36 Million ≈ $9.62 Million	Skr594.31 Million ≈ $63.96 Million	-13.60pp
2020-12-31	28.64%	Skr247.28 Million ≈ $26.61 Million	Skr863.54 Million ≈ $92.93 Million	+5.35pp
2019-12-31	23.28%	Skr234.08 Million ≈ $25.19 Million	Skr1.01 Billion ≈ $108.19 Million	+23.28pp
2018-12-31	0.00%	Skr1.00 ≈ $0.11	Skr646.38 Million ≈ $69.56 Million	-3.88pp
2015-12-31	3.88%	Skr20.01 Million ≈ $2.15 Million	Skr515.58 Million ≈ $55.48 Million	-5.87pp
2014-12-31	9.75%	Skr50.15 Million ≈ $5.40 Million	Skr514.57 Million ≈ $55.38 Million	--

pp = percentage points

About Vivesto AB

ST:VIVE Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$10.37 Million

Skr96.32 Million SEK

Market Cap Rank

#26939 Global

#584 in Sweden

Share Price

Skr8.70

Change (1 day)

+3.82%

52-Week Range

Skr0.08 - Skr17.00

All Time High

Skr17.00